- Reports /
- Patient Engagement Solutions Market
Patient Engagement Solutions Market
Patient Engagement Solutions Market Market Research Report – Segmented By Component (Hardware, Software, Services), By Delivery Mode (On-premise Solutions, Cloud-based Solutions), By End User (Providers, Payers, Patients, Other End Users), By Application (Health Management, Home Health Management, Social And Behavioral Management, Financial Health Management), By Therapeutic Area (Chronic Diseases, Women’s Health, Fitness, Other Therapeutic Areas) & Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2027.
Table of contents
- Executive Summary
- Market Overview
- Industry Analysis
- Market Analysis
- By Component
- By Delivery Mode
- By End User
- By Application
- By Therapeutic Area
- North America
- Europe
- Asia-Pacific
- Middle-East & Africa
- Latin America
- Company Analysis
- Competitive Analysis
- Research Methodology
- Appendix
Executive Summary
Patient Engagement Solutions Market was valued at US $19.08 billion in 2021 and is projected to grow at 10.29% CAGR over the forecast period to reach US $34.35 billion by 2027. Patient Engagement Solutions Market represented US $3.40 billion opportunity over 2019-2021 and estimated to create US $15.27 billion opportunity in 2027 over 2021.
Patient Engagement Solutions from Consainsights analyses the Patient Engagement Solutions Market in the Life Sciences industry over the forecast period to 2027.
Patient Engagement Solutions research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.
Patient Engagement Solutions segmentation includes Component, Delivery Mode, End User, Application, Therapeutic Area and Geography.
Based on the Component, the Patient Engagement Solutions analysis covers Hardware, Software, Services.
In Component segment, Hardware segment has highest cagr growth of 9.10%.
Based on the Delivery Mode, the Patient Engagement Solutions analysis covers On-premise Solutions, Cloud-based Solutions.
In Delivery Mode segment, On-premise Solutions segment has highest cagr growth of 9.10%.
Based on the End User, the Patient Engagement Solutions analysis covers Providers, Payers, Patients, Other End Users.
In End User segment, Providers segment has highest cagr growth of 9.10%.
Based on the Application, the Patient Engagement Solutions analysis covers Health Management, Home Health Management, Social And Behavioral Management, Financial Health Management.
In Application segment, Health Management segment has highest cagr growth of 9.10%.
Based on the Therapeutic Area, the Patient Engagement Solutions analysis covers Chronic Diseases, Women’s Health, Fitness, Other Therapeutic Areas.
In Therapeutic Area segment, Chronic Diseases segment has highest cagr growth of 9.10%.
Based on the region, the Patient Engagement Solutions analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.
Key companies operating in the market include Mckesson, Allscripts, Ibm, Athenahealth, Orion Health, Cerner, Getwellnetwork, Lincor Solutions, Yourcareuniverse, Welvu, Get Real Health, Oneview Healthcare and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.
Market Overview
Definition & Scope
The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
Currency, Year & Forecast
The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
Component
Introduction
In 2021, Software segment has the highest revenue of US $7.71 billion and is expected to grow at CAGR of 9.10% by 2027 Hardware segment has highest cagr growth of 9.10%.
Hardware
Hardware segment was valued at US $5.73 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $12.54 billion by 2027. Hardware segment represented US $1.24 billion opportunity over 2019-2021 and estimated to create US $5.58 billion opportunity in 2027 over 2021.
Software
Software segment was valued at US $6.33 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $13.87 billion by 2027. Software segment represented US $1.37 billion opportunity over 2019-2021 and estimated to create US $6.17 billion opportunity in 2027 over 2021.
Services
Services segment was valued at US $3.62 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $7.93 billion by 2027. Services segment represented US $0.78 billion opportunity over 2019-2021 and estimated to create US $3.53 billion opportunity in 2027 over 2021.
Delivery Mode
Introduction
In 2021, On-premise Solutions segment has the highest revenue of US $15.02 billion and is expected to grow at CAGR of 9.10% by 2027 On-premise Solutions segment has highest cagr growth of 9.10%.
On-premise Solutions
On-premise Solutions segment was valued at US $12.34 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $27.03 billion by 2027. On-premise Solutions segment represented US $2.67 billion opportunity over 2019-2021 and estimated to create US $12.01 billion opportunity in 2027 over 2021.
Cloud-based Solutions
Cloud-based Solutions segment was valued at US $3.34 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $7.32 billion by 2027. Cloud-based Solutions segment represented US $0.72 billion opportunity over 2019-2021 and estimated to create US $3.25 billion opportunity in 2027 over 2021.
End User
Introduction
In 2021, Providers segment has the highest revenue of US $9.55 billion and is expected to grow at CAGR of 9.10% by 2027 Providers segment has highest cagr growth of 9.10%.
Providers
Providers segment was valued at US $7.85 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $17.20 billion by 2027. Providers segment represented US $1.70 billion opportunity over 2019-2021 and estimated to create US $7.64 billion opportunity in 2027 over 2021.
Payers
Payers segment was valued at US $4.60 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $10.08 billion by 2027. Payers segment represented US $1.00 billion opportunity over 2019-2021 and estimated to create US $4.48 billion opportunity in 2027 over 2021.
Patients
Patients segment was valued at US $2.61 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $5.72 billion by 2027. Patients segment represented US $0.57 billion opportunity over 2019-2021 and estimated to create US $2.54 billion opportunity in 2027 over 2021.
Other End Users
Other End Users segment was valued at US $0.62 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $1.35 billion by 2027. Other End Users segment represented US $0.13 billion opportunity over 2019-2021 and estimated to create US $0.60 billion opportunity in 2027 over 2021.
Application
Introduction
In 2021, Health Management segment has the highest revenue of US $8.44 billion and is expected to grow at CAGR of 9.10% by 2027 Health Management segment has highest cagr growth of 9.10%.
Health Management
Health Management segment was valued at US $6.94 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $15.19 billion by 2027. Health Management segment represented US $1.50 billion opportunity over 2019-2021 and estimated to create US $6.75 billion opportunity in 2027 over 2021.
Home Health Management
Home Health Management segment was valued at US $4.87 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $10.66 billion by 2027. Home Health Management segment represented US $1.05 billion opportunity over 2019-2021 and estimated to create US $4.74 billion opportunity in 2027 over 2021.
Social And Behavioral Management
Social And Behavioral Management segment was valued at US $2.10 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $4.61 billion by 2027. Social And Behavioral Management segment represented US $0.46 billion opportunity over 2019-2021 and estimated to create US $2.05 billion opportunity in 2027 over 2021.
Financial Health Management
Financial Health Management segment was valued at US $1.78 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $3.89 billion by 2027. Financial Health Management segment represented US $0.38 billion opportunity over 2019-2021 and estimated to create US $1.73 billion opportunity in 2027 over 2021.
Therapeutic Area
Introduction
In 2021, Chronic Diseases segment has the highest revenue of US $7.71 billion and is expected to grow at CAGR of 9.10% by 2027 Chronic Diseases segment has highest cagr growth of 9.10%.
Chronic Diseases
Chronic Diseases segment was valued at US $6.34 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $13.88 billion by 2027. Chronic Diseases segment represented US $1.37 billion opportunity over 2019-2021 and estimated to create US $6.17 billion opportunity in 2027 over 2021.
Women’s Health
Women’s Health segment was valued at US $4.18 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $9.15 billion by 2027. Women’s Health segment represented US $0.90 billion opportunity over 2019-2021 and estimated to create US $4.07 billion opportunity in 2027 over 2021.
Fitness
Fitness segment was valued at US $3.04 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $6.66 billion by 2027. Fitness segment represented US $0.66 billion opportunity over 2019-2021 and estimated to create US $2.96 billion opportunity in 2027 over 2021.
Other Therapeutic Areas
Other Therapeutic Areas segment was valued at US $2.13 billion in 2019 and is projected to grow at 9.10% CAGR over the forecast period to reach US $4.66 billion by 2027. Other Therapeutic Areas segment represented US $0.46 billion opportunity over 2019-2021 and estimated to create US $2.07 billion opportunity in 2027 over 2021.